CVE-2015-1012

Description

Wireless keys are stored in plain text on version 5 of the Hospira LifeCare PCA Infusion System. According to Hospira, version 3 of the LifeCare PCA Infusion System is not indicated for wireless use, is not shipped with wireless capabilities, and should not be modified to be used in a wireless capacity in a clinical setting. Hospira has developed a new version of the PCS Infusion System, version 7.0 that addresses the identified vulnerabilities. Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.

Categories

7.5
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.14%
Third-Party Advisory us-cert.gov
Affected: Hospira LifeCare PCA Infusion System
Published at:
Updated at:

References

Link Tags
https://ics-cert.us-cert.gov/advisories/ICSA-15-125-01 mitigation third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2015-1012?
CVE-2015-1012 has been scored as a high severity vulnerability.
How to fix CVE-2015-1012?
To fix CVE-2015-1012, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2015-1012 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2015-1012 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2015-1012?
CVE-2015-1012 affects Hospira LifeCare PCA Infusion System.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.